Nxera Pharma Co (Nxera Pharma Co) Net Interest Income : $-6.8 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Nxera Pharma Co's net interest income for the three months ended in Mar. 2024 was $1.9 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2024 was $-6.8 Mil.

Nxera Pharma Co Net Interest Income Historical Data

The historical data trend for Nxera Pharma Co's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Net Interest Income Chart

Nxera Pharma Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Interest Income

Get a 7-Day Free Trial

3.03

10.12

-31.61

-0.69

-8.02

Nxera Pharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Interest Income	Get a 7-Day Free Trial															0.76	2.17	-1.90	-8.90	1.87

Nxera Pharma Co Net Interest Income Calculation

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.8 Mil.

Nxera Pharma Co Net Interest Income Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co (Nxera Pharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » Net Interest Income

Comparable Companies

Traded in Other Exchanges

4565:Japan JSS:Germany

Address

2-1 Kojimachi, Chiyoda-ku, PMO Hanzomon 11th Floor, Tokyo, JPN, 102-0083

Website

http://www.sosei.com

Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.